ReviewCurrent topics in medicinal chemistry2014

Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease.

Elizabeth A Ottinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.